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Abstract
Background: Nucleolin is a major component of the nucleolus, but is also found in other cell
compartments. This protein is involved in various aspects of ribosome biogenesis from
transcription regulation to the assembly of pre-ribosomal particles; however, many reports suggest
that it could also play an important role in non nucleolar functions. To explore nucleolin function
in cell proliferation and cell cycle regulation we used siRNA to down regulate the expression of
nucleolin.
Results: We found that, in addition to the expected effects on pre-ribosomal RNA accumulation
and nucleolar structure, the absence of nucleolin results in a cell growth arrest, accumulation in
G2, and an increase of apoptosis. Numerous nuclear alterations, including the presence of
micronuclei, multiple nuclei or large nuclei are also observed. In addition, a large number of mitotic
cells showed a defect in the control of centrosome duplication, as indicated by the presence of
more than 2 centrosomes per cell associated with a multipolar spindle structure in the absence of
nucleolin. This phenotype is very similar to that obtained with the inactivation of another nucleolar
protein, B23.
Conclusion: Our findings uncovered a new role for nucleolin in cell division, and highlight the
importance of nucleolar proteins for centrosome duplication.
Background
There is increasing evidence that nucleoli play important
roles in the regulation of many fundamental cellular proc-
esses, including cell cycle regulation, apoptosis, telomer-
ase production, RNA processing, monitoring and
response to cellular stress [1-3]. These multiple functions
can be achieved by the transient localization of several
hundred proteins within the nucleolar structure [4]. In
addition, several well known nucleolar proteins seem to
have multiple functions. Amongst them, the abundant
nucleolar proteins nucleophosmin (B23) and nucleolin
(C23) have been the subject of numerous studies.
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Although nucleophosmin and nucleolin do not share any
structural homology, they seem to have numerous func-
tions in common. The predominant location of these pro-
teins in the nucleolus strongly suggested that they could
be involved in ribosome biogenesis. Both proteins inter-
act with nucleic acids [5,6], and could be viewed as ribos-
ome assembly factors. Despite the fact that
endoribonuclease and molecular chaperone activities
have been reported for nucleophosmin [7-9], its contribu-
tion to ribosome biogenesis is still unclear. The function
of nucleolin in ribosome biogenesis has been well docu-
mented [10,11]. Its interaction with ribosomal proteins
[12] and with specific pre-rRNA sequences [6,13,14], and
its implication in the first step of pre-rRNA maturation
[15], also suggest that nucleolin could be an important
ribosome assembly factor. In addition, nucleolin seems to
be involved in the control of pre-rRNA accumulation [16-
18].
Several observations suggest that nucleolin is also a major
actor in promoting cell proliferation. Nucleolin levels are
higher in tumours and actively dividing cells [19-23], and
are widely used as a marker of cell proliferation. Further-
more, overexpression of nucleolin cooperates with onco-
genic mutant Ras in a rat embryonic fibroblast
transformation assay [24].
Nucleolin seems to be able to affect ribosomal RNA gene
expression in different ways. A strong link between nucle-
olin phosphorylation, proteolysis and the production of
ribosomal RNA has been observed [25-27]. The inhibi-
tion of nucleolin proteolysis leads to lower rRNA tran-
scription in an in vitro transcription system [27], while the
injection of nucleolin antiserum leads to 2–3.5 fold stim-
ulation of pre-rRNA synthesis in Chironomus tentans sali-
vary glands [28]. Injection of a 2–4 fold excess of
nucleolin in Xenopus laevis stage IV oocytes also leads to a
significant reduction in the accumulation of 40 S pre-RNA
[17]. It has also been demonstrated that nucleolin phos-
phorylation can be triggered by a variety of stimuli such as
androgens and growth factors [29-33], and that this phos-
phorylation is invariably accompanied by increased rRNA
transcription and cell proliferation.
In addition to nucleolar functions, nucleophosmin and
nucleolin seems to share additional functions. Both pro-
teins are histone chaperones [34,35], and appear to be
involved in different aspects of DNA metabolism and
chromatin regulation [36,37].
Nucleophosmin is also directly implicated in cancer
pathogenesis, as the NPM1 gene is found mutated and
rearranged in a number of haematological disorders [38].
Nucleophosmin is essential for mouse embryonic devel-
opment, as the inactivation of the Npm1 gene leads to
unrestricted centrosome duplication and genomic insta-
bility [39]. It has been proposed that during mitosis,
nucleophosmin associates with duplicated centrosomes
and prevents their reduplication until the G1/S phase,
when it dissociates from them after phosphorylation by
Cdk2/E [40,41]. Wang et al. further showed that the cen-
trosomal association of nucleophosmin relies on the Ran-
Crm1 complex [42]. Although nucleolin has not previ-
ously been shown to be involved in the regulation of cen-
trosome duplication, it is interesting to note that
nucleophosmin interacts directly with nucleolin [43], and
that a nucleolin-like protein, together with other nucleo-
lar proteins, has been found associated with centrosomal
structure [44].
To determine the function of nucleolin in cell prolifera-
tion and cell cycle regulation we used siRNA to knock
down nucleolin expression. We found that nucleolin is
not only required for cell proliferation, but that its down
regulation also leads to unrestricted centrosome duplica-
tion, as described for the inactivation of nucleophosmin.
Results
Nucleolin is required for nucleolar structure formation
Nucleolin is highly expressed in proliferating cells, and is
believed to be important for cell growth. In order to study
the role of nucleolin in cell proliferation, we tested differ-
ent siRNA for their ability to significantly decrease the
amount of nucleolin in human cells. Preliminary experi-
ments with 4 different siRNA sequences directed against
distinct domains of nucleolin and 2 siRNA controls (See
Additional file 1) were performed and allowed us to select
the best siRNA duplexes able to induce a significant
decrease of nucleolin expression. Of these 4 siRNA, two
significantly reduced nucleolin protein levels (#2 and #4,
see Additional file 2). Neither one of the 2 control siRNA
was able to significantly reduce the level of nucleolin pro-
tein. A mixture of siRNA #2 and #4 were transfected in
HeLa cells or in a primary culture of human fibroblast, fol-
lowed by time course kinetics of nucleolin expression
inhibition (Figure 1A, B). In both HeLa cells and human
primary fibroblasts, the level of nucleolin protein started
to decrease 2 days after siRNA transfection to reach a min-
imum after 4–5 days, corresponding to a decrease of
about 80% (Figure 1B). Interestingly, the level of B23 (Fig-
ure 1A) and fibrillarin (data not shown), other abundant
nucleolar proteins, was not affected by the decreased
nucleolin expression. This lower level of protein expres-
sion was perfectly correlated with a decrease in nucleolin
coding mRNA (Figure 1C). Nucleolin mRNA levels
remained low for at least 4 days. The decrease in nucleolin
protein levels was confirmed by immunofluorescence
analysis of HeLa cells transfected with nucleolin siRNA
(mix of #2 and #4) (Figure 1D, panel B) compared to con-
trol cells transfected with the scrambled siRNA (#1). InBMC Molecular Biology 2007, 8:66 http://www.biomedcentral.com/1471-2199/8/66
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addition, these microscopic observations also indicated
an important morphological modification of nuclei that
expressed low levels of nucleolin. These nuclei appeared
bigger and more rounded with a single large nucleolar
body (Figure 1D, panels B1 to B3) compared to cells trans-
fected with the siRNA control #1 (Figure 1D, panel A).
Since nucleolin is a major protein of the nucleolus, one
might expect that depletion of nucleolin would affect
nucleolar structure. As seen by electron microcopy, the
nucleolus consists of three main components, designated
fibrillar centers (FC), dense fibrillar components (DFC),
and granular components (GC). Ribosomal RNA genes
are localized in the FC, pre-rRNA resides in the DFC, while
late processing steps of ribosome biogenesis are found in
GC. In untransfected control and in scrambled siRNA
transfected cells, FC is found in the center of the nucleolar
structure, surrounded by the DFC. The DFC is in turn sur-
rounded by GC, which fills out the peripheral parts of the
nucleolus (see Figure 2A, a-untransfected control). Nucle-
olin is usually found in the DFC and GC of nucleoli, UBF
(Upstream Binding Factor) in the FC, and fibrillarin in the
DFC. Electron microscopy analysis of control and siRNA
transfected cells revealed a profound modification of the
different nucleolar compartments in absence of nucleolin
(Figure 2A, panels c and d), associated with an apparent
increase of the nucleolar volume. Fibrillar centers and
dense fibrillar centers were observed at the periphery of
the granular component, and a complete segregation of
these compartments could even be observed at later time
points following transfection (Figure 2A, panel d). This
reorganization of the nucleolar compartment was con-
firmed by immunofluorescence analysis of nucleolin,
UBF and fibrillarin in cells transfected with a control
scrambled siRNA, and in nucleolin depleted cells (Figure
2B, C). In interphase control cells, UBF was mainly
present in foci that probably correspond to the internally
localized FC, whereas nucleolin labeled nucleolar
peripheric structures corresponding to DFC and GC. Inter-
estingly, in nucleolin depleted cells, UBF no longer
appeared as foci, but as ring-like structures surrounding
the DAPI depleted regions (Figure 2B). This staining could
correspond to the delocalized FC observed by electron
microscopy (Figure 2A, c–d). In contrast, the localization
of fibrillarin does not seem to be affected in nucleolin
depleted HeLa cells (Figure 2C). This segregation of nucle-
olar compartments was also found when cells were treated
with low amounts of actinomycin D, an inhibitor of
polymerase I transcription [45-47]. To determine if the
lower expression of nucleolin led to a lower accumulation
of pre-ribosomal RNA, cells were collected at different
times after siRNA transfection, and the 45S pre-rRNA ana-
lyzed by northern blot (Figure 2D) or quantitative RT-PCR
(Figure 2E). Using these two techniques, we found that
nucleolin depletion leads to a 5–6 fold reduction of 45S
accumulation, as expected [16-18].
Nucleolin has been implicated in vitro in the first process-
ing step of pre-rRNA [15]. It was therefore interesting to
determine if down-regulation of nucleolin was able to
modify the efficiency of this processing step in vivo. Anal-
ysis of the efficacy of this first processing step in HeLa cells
did not allow us to detect significant changes in the level
of cleavage within the 5'ETS upon nucleolin depletion
(data not shown). In addition, the general pattern of pre-
rRNA processing did not seem to be altered. The low level
of remaining nucleolin might be sufficient to allow for
correct processing. Furthermore, since this primary
processing step within the 5'ETS cleavage is not complete
in these cells, and it is not known how it is regulated when
polymerase I transcription is inhibited, it might be diffi-
cult in this experimental system, to detect the effect of
nucleolin depletion on this cleavage.
Nucleolin regulates cell proliferation and cell cycle 
progression
To determine if nucleolin depletion affects cell prolifera-
tion, the growth rate of these cells was measured and com-
pared to that of cells transfected with scrambled siRNA
and untransfected control cells. This was achieved by
counting cells at different time points after transfection of
siRNA #2 and #4 (Figure 3A). As soon as the level of
nucleolin protein decreased (second day after transfec-
tion, see Figure 1B), the number of cells increased more
slowly and was almost steady compared to untransfected
cells or to cells transfected with a scrambled siRNA, sug-
gesting that cell growth was affected by low nucleolin
amount. To determine if cell growth was blocked at a spe-
cific phase of the cell cycle, flow cytometry analysis
(FACS) was performed on siRNA transfected and control
HeLa cells (Figure 3B). Transfection of control siRNA did
not change the cell cycle profile of HeLa cells (Additional
file 3), whereas transfection of the mix of siRNA #2 and #4
significantly altered the cell cycle (Figure 3B). During
nucleolin time-course depletion, cell cycle analysis
showed a progressive and significant decrease in the cell
population with a 2n DNA content (G1: 53% in untran-
fected population to 37.9% in population transfected for
3 days to 23% in population tranfected for 5 days, Figure
3B), whereas a progressive and significant increase was
observed in the population with a 4n DNA content (G2/
M: 7% in untranfected population to 16.2% in popula-
tion transfected for 3 days to 19% in population tran-
fected for 5 days, Figure 3B). Based on this cell cycle
analysis, the number of cells in S phase was approximately
unchanged (36.5% to 35.4% to 34.7%, Figure 3B). The
stability of the S-phase population upon nucleolin deple-
tion was confirmed by manually counting cells exhibiting
a positive BrdU staining under the microscope (Addi-BMC Molecular Biology 2007, 8:66 http://www.biomedcentral.com/1471-2199/8/66
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siRNA – mediated down regulation of nucleolin Figure 1
siRNA – mediated down regulation of nucleolin. A. Western blots of nucleolin protein in untransfected control cells, 
mock (transfected with siRNA control #1) and siRNA against nucleolin (mix siRNA #2 and #4) treated cells. At the indicated 
times, HeLa and human primary fibroblast cells were harvested and protein extracts were analyzed by Western blotting with 
anti-nucleolin antibody. Equal loading was verified using anti-tubulin antibodies. The amount of B23 protein was also analyzed 
using anti-B23 antibodies. B. Quantification of the Western blots. Data were normalized to the tubulin protein. The normalized 
nucleolin protein level was set to 100% in control cells. Data are from three independent experiments. C. Quantitative RT-
PCR. At indicated times after transfection, HeLa and human primary fibroblast cells were harvested, total RNA was isolated 
and used for cDNA synthesis and quantitative PCR with nucleolin or cytoplasmic β-actin specific primers. Data were normal-
ized to the amount of β-actin mRNA. Untransfected control and scrambled (transfected with scrambled siRNA) cells were also 
used and all data were normalized to the amount of nucleolin mRNA in control cells. Data are from three independent exper-
iments. D. Immunofluorescence analysis. Four days after siRNA transfection (control scrambled siRNA #1, panels A, or mix of 
siRNA #2 and #4 panels B), HeLa cells were examined by immunofluorescence using anti-nucleolin antibody in green. DNA 
was counterstained with DAPI (Blue). In panels A.1 to A.3 and B.1 to B.3, a zoom on one representative cell is shown to high-
light the modification of the shape and number of nucleolar structures after nucleolin depletion. Bars represent 10 µm.
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The nucleolar structure is disrupted in nucleolin depleted cells Figure 2
The nucleolar structure is disrupted in nucleolin depleted cells. A. Electron micrographs of nucleoli in control 
untransfected cells (a), mock transfected cells with scrambled siRNA (b) and cells transfected with nucleolin mix siRNA #2 and 
#4 (c, d). Cells were fixed 3 days (a, c) or 5 days after transfection (b and d). FC: fibrillar center; DFC: dense fibrillar compo-
nent; GC: granular component. Bar represents 1 µm. B and C. Co-detection of nucleolin (green) and UBF (B, red) or fibrillarin 
(C, red) in HeLa cells transfected with control siRNA or with nucleolin mix siRNA #2 and #4, 5 days after transfection. Images 
of DNA counterstaining by DAPI are also shown. Images correspond to a projection of several deconvolved sections acquired 
every 0.2 µm. An interphase nucleus and a mitotic cell are shown in each panel. Bars represent 10 µm. D and E. Accumulation 
of pre-ribosomal RNA in HeLa cells transfected with control siRNA or with nucleolin mix siRNA #2 and #4. Total RNA was 
extracted at different days after transfection and used for northern blot analysis (D) or quantitative RT-PCR (E). For the 
northen blot, an oligonucleotide complementary to the 5'ETS was used as a probe. The blot was also hybridized with a probe 
specific for β actin to normalize the data. Ethidium bromide staining (18S-EtBr) of the gel before transfer is also shown to show 
RNA integrity and equal loading of RNA (E). The normalized data of the northern blots are shown, together with the data of 
the quantitative RT-PCR, and with the amount of nucleolin protein present in these cells as determined by nucleolin western 
blot (not shown).
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tional file 4). Similar trends were observed when cell cycle
progression was analyzed on primary fibroblast cultures
transfected with control siRNA or with a mix of siRNA #2
and 4 directed against nucleolin (data not shown). siRNA
duplexes that have no effect on nucleolin protein levels
(#1 and #3) also have no effect on cell cycle progression
(see Additional file 3), further showing that the observed
cell cycle effects are the consequence of the specific deple-
tion of nucleolin.
To determine if the absence of nucleolin was able to affect
mitotic progression, we measured the effect of nucleolin
depletion on the number of cells in mitosis (Figure 3C
and Additional file 5). HeLa and fibroblast cells were
transfected with control or anti-nucleolin siRNA, and cul-
tured for 4 days before fixation and staining with DAPI,
and immuno-detection of either phosphorylated serine
28 of histone H3 (PH3-S28), or cyclin B1, to identify
mitotic cells. PH3-S28 labeling and DAPI staining showed
a significant decrease in mitotic cells (about 65% decrease
in HeLa and 90% decrease in fibroblast, Additional file 5).
The decrease in the mitotic index upon nucleolin deple-
tion was further confirmed by an increase in cyclin B1
staining of chromatin, observed concomitantly with
nuclear envelope break down at the beginning of mitosis
(Additional file 5). Altogether these results are indicative
of a mitotic index reduction (Figure 3C). Therefore, the
overall increase in the G2/M population observed by flow
cytometry upon nucleolin depletion is not due to an
increase in the mitotic population, but is likely to repre-
sent an increase in the G2 population. To confirm this
hypothesis, immunofluorescence with an antibody
against phosphorylated serine 10 of histone H3 (PH3-
S10), a G2 marker [48], was performed (Additional file 4).
The data show an about 2-fold increase in cells labeled
with PH3-S10 upon nucleolin depletion. Therefore, the
net gain in cells exhibiting a G2 marker contributes largely
to the increased population exhibiting the G2/M DNA
content observed upon nucleolin depletion.
As a small number of cells showed polyploidy upon
nucleolin depletion (Figure 3B, 5 days), we wanted to ask
whether tetraploid cells with a 2n DNA content contribute
to the increase in the population size exhibiting a the G2/
M DNA content. In situ hybridization performed with a
probe specific to the centromere of chromosome 10 on
cells transfected with siRNA against nucleolin revealed
only very few nuclei with twice the number of hybridiza-
tion signals observed in control cells (data not shown).
This result suggests that tetraploid cells do not signifi-
cantly contribute to the observed increase in the popula-
tion exhibiting a G2/M DNA content observed upon
nucleolin depletion. Therefore the increase in G2/M pop-
ulation upon nucleolin depletion can be mainly
explained by an increase in diploid G2 cells.
Five days after transfection, about 20% of HeLa cells had
a sub-2N DNA content (Sub G1) compared to 3.2% in
untransfected control cells (Figure 3B). Consistent with
that, tunnel assays (Figure 4A, B) revealed about 22% of
apoptotic cells 5 days after transfection. Thus, depletion of
nucleolin in HeLa cells triggers apoptosis. Nucleolar dis-
ruption in response to cellular stress has been found to
stabilize p53 [49]. Indeed, we observed a marked increase
in p53 protein levels after depletion of nucleolin (Figure
4C and 4D). This increase may be the consequence of p53
protein stabilization. However, a 2-fold increase of p53
mRNA could also be observed in both HeLa and fibrob-
last transfected cells (Figure 4E). To determine if apoptosis
was responsible for the large reduction in cell growth,
observed upon nucleolin depletion (see above) we per-
formed a simulation to remove the contribution of cell
death by apoptosis on measured growth curves (see Figure
3A). The growth curve obtained for cells transfected with
control siRNA was used as a starting point to calculate the
estimated curve (Additional file 6). The percentage of
apoptotic cells measured during a 4 day time course (Fig-
ure 4B) was subtracted from the total cell population at
each time point to remove the apoptotic population from
the growing cell population. The reevaluating growth
curve was, as expected, below the growth curve obtained
for cells transfected with control siRNA, but significantly
much higher than the growth curve measured for cells
transfected with siRNA against nucleolin (Figure 4B, com-
pare dash curve to plain curves). Our result indicates that
in addition to apoptosis induction, nucleolin depletion
reduces cell proliferation. Therefore, apoptosis and cell
proliferation reduction both act synergistically and ulti-
mately lead to cell growth arrest.
Inhibition of nucleolin expression induces multiple nuclear 
alterations and centrosome amplification
Observation of nucleolin depleted cells also revealed a
large increase in nuclear alterations (Figure 5A, B). In par-
ticular, the presence of cells with micronuclei or multiple
nuclei was drastically increased in transfected cells. Com-
pared to HeLa cells, this increase was even more pro-
nounced in human primary fibroblasts, which exhibit
almost no micronuclei or multinuclei in the population
of cells transfected with scrambled siRNA. The presence of
these defects could be the consequence of abnormal mito-
sis caused by amplified centrosomes [50]. To test the
hypothesis that the depletion of nucleolin could lead to
abnormalities in centrosome duplication, cells transfected
with siRNA against nucleolin or control siRNA were
stained with an anti-γ-tubulin antibody to detect the cen-
trosomal structures, an anti-α-tubulin antibody to detect
microtubules, a CREST serum (CEN) for the centromeres,
and DAPI for DNA. As observed on 3D reconstructions of
mitotic cells (Figure 6), more than 2 signals were consist-
ently observed for γ-tubulin in siRNA transfected HeLaBMC Molecular Biology 2007, 8:66 http://www.biomedcentral.com/1471-2199/8/66
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Nucleolin depletion leads to decreased cell growth and G2/M accumulation Figure 3
Nucleolin depletion leads to decreased cell growth and G2/M accumulation. A. Growth curves of HeLa cells, 
untransfected or transfected with control siRNA # 1 or the siRNA mix #2 and #4. Cells were counted at the indicated time 
after transfection. The graph represents the average of 5 independent experiments. B. Analysis of cell cycle in nucleolin 
depleted cells. Untransfected and transfected HeLa cells were stained with propidium iodide and processed for FACS analysis. 
Histograms from a representative experiment showing G1 and G2/M populations shaded in red and S phase population in blue. 
Sub G1 represent apoptotic cell population. The vertical and the horizontal axes represent respectively cell number and DNA 
fluorescence intensity. The percentages of cells in individual cell cycle phases were quantified with ModFit LD software. C. 
Mitotic index of HeLa cells and human primary fibroblasts transfected with control siRNA or the siRNA mix #2 and #4. After 
4 days of transfection, cell populations were stained with an anti phospho S28-H3 antibody and cyclin B1 to detect mitotic cells. 
Positive cells were scored by microscopic observation. This graph represents the average of the different experiments (DAPI, 
PH3S28 and cyclin B1) shown in additional file 5.
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Nucleolin depletion activates apoptotic pathways Figure 4
Nucleolin depletion activates apoptotic pathways. A. TUNEL staining. HeLa cells transfected with control siRNA # 1 or 
the nucleolin siRNA mix #2 and #4 were subjected to TUNEL staining 4 days after transfection. B. Quantification of TUNEL-
positive cells by counting at least 400 cells in two independent experiments. Error bars indicate ± SD. C. Western blots. At 
indicated times, protein extracts were analyzed by Western blotting with anti-nucleolin and anti-p53 antibodies. Normalization 
was performed with tubulin. D. Immunofluorescence of p53 of control or anti-nucleolin siRNA transfected cells 4 days post-
transfection. E. Quantitative RT-PCR. Primers to β-actin and p53 were used. Levels of p53 mRNA were calculated against the 
level of β-actin mRNA as reference gene.
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cells compared to 2 signals in control cells. Centrosome
amplification in siRNA depleted mitotic cells was associ-
ated with the presence of a multipolar spindle as detected
by α-tubulin staining (Figure 6).
Discussion
Many reports suggest that nucleolin plays important roles
in ribosome biogenesis, ranging from rDNA transcription
to the assembly of the pre-ribosomal particles [11], and
that this multifunctional protein may have a more general
role in gene regulation through its involvement in chro-
matin structure and dynamics [35,37]. Nucleolin is highly
expressed in tumors and actively dividing cells [51,52],
and is often used as a marker for cell proliferation. Its abil-
ity to cooperate with Ras in a rat embryonic transforma-
tion assay [24], to repress translation of p53 mRNA [24],
and to act as the target of the anti-proliferative GROs (G-
rich oligonucleotides) [53,54], suggests that nucleolin
could directly affect cell proliferation independently of its
action in ribosome biogenesis.
To explore the role of nucleolin in cell proliferation, we
used siRNA to repress the expression of nucleolin protein
in HeLa cells and in cultured human primary fibroblasts.
As soon as a significant decrease in the levels of nucleolin
protein could be observed (2 fold decrease, 2 days after
transfection), cells stopped proliferating (Figure 3), and a
significant number of cells entered apoptosis (Figure 4).
The slower growth of cells depleted in nucleolin is proba-
bly not the consequence of widespread alteration in gene
expression. We performed protein labelling experiments
in nucleolin depleted cells and did not observed major
alterations in protein synthesis in these cells (data not
shown). In addition, we have performed transcriptome
analysis of HeLa and human fibroblast cells depleted in
nucleolin. Surprisingly, only a limited number of genes
(~0.1% of the genes present on the microarray) seem sig-
nificantly affected (data not shown), suggesting that the
slow growth of nucleolin depleted cells is not the result of
a global effect of nucleolin on gene expression. Instead,
changes in the expression of specific genes, such as p53
(Figure 4) might be responsible for slow growth and
apoptosis. Future experiments will explore the different
pathways that are activated upon nucleolin depletion.
One of the most drastic modifications of the ultra struc-
ture of the cell was the rearrangement of the nucleolar
compartment (Figure 2). Fibrillar centers and dense fibril-
lar centers were delocalized to the periphery of the granu-
lar component, and a complete segregation of these
compartments was also observed at later time points after
siRNA transfection. This nucleolar reorganization had
some resemblance to that obtained after the inhibition of
rDNA transcription with low amount of actinomycin D
[45-47], with injection of anti-UBF antibodies [49], or
TIF-IA inactivation [55]. Indeed, we also observed that in
nucleolin depleted cells, rDNA transcription was lower
than in control cells (Figure 2D, E). However, unlike these
earlier studies, we failed to observe a release of the major
nucleolar proteins fibrillarin, UBF (figure 2B and 2C) or
B23 (data not shown) in the nucleoplasm. Instead, UBF
remained associated with the reorganized fibrillar compo-
nent in interphase cells.
As previously described [49,55] this nucleolar disruption
is accompanied by elevated levels of p53 protein (Figure
4). The increase in p53 levels was likely the consequence
of the increased translation of p53 mRNA [24] and/or sta-
bilization of p53 mRNA (Figure 4). As we have not
directly tested if the interaction of HDM2 (mouse Double
Minute 2 Human homolog) with p53 was altered in
nucleolin deficient cells, we cannot exclude the possibility
that the elevated level of p53 was also due to inhibition of
HDM2, as previously reported [55,56].
One of the most remarkable consequences of nucleolin
inactivation is the apparent blockage of cells in the G2
phase (Figure 3), and the significant increase in multinu-
clear cells and cells with micronuclei (Figure 5). By con-
trast, the number of cells in mitosis was drastically
reduced in nucleolin depleted cells (Figure 3E, Additional
file 5). Furthermore, in situ hybridization with a probe
specific to the pericentromeres of chromosome 10 did not
detect any significant increase in tetraploid cells, suggest-
ing that cells are probably arrested in G2. This phenotype
is quite different from that obtained upon inactivation of
TIF-IA [55], but similar to that obtained upon inactivation
of B23 [39]. Furthermore, as with the inactivation of B23,
we also observed an alteration in the control of centro-
some number in cells expressing low levels of nucleolin
(Figure 6). Interestingly, it was also recently reported that
nucleolin was required for chromosome congression and
the maintenance of mitotic spindle integrity [57], suggest-
ing that nucleolin may have a more general role during
mitosis.
It is also striking that nucleolin and B23 share numerous
homologous functions, despite the fact that they have dif-
ferent structures. Both interact with nucleic acids [5,11],
shuttle between the nucleus and cytoplasm [58], and are
involved in different aspects of ribosome biogenesis [10]
and in chromatin regulation [34,35]. This report high-
lights other possible common properties of nucleolin and
B23 in cell proliferation control and centrosome duplica-
tion.
It has been proposed that during mitosis, when the
nuclear envelope breaks down, some B23 is delocalized
from the nucleolus to centrosomes where it remains
bound until it is phosphorylated by CDK2/cyclin E atBMC Molecular Biology 2007, 8:66 http://www.biomedcentral.com/1471-2199/8/66
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Nucleolin depletion induces the formation of micronuclei and multinuclear cells Figure 5
Nucleolin depletion induces the formation of micronuclei and multinuclear cells. A. Images of HeLa cells or human 
primary fibroblasts transfected for 4 days with scrambled siRNA #1 or with nucleolin siRNA mix #2 and #4 were counter-
stained with DAPI and visualized at the same magnification. Micronuclei are observed on A6 and A7, multinuclear cells are 
observed on A3, A4 and A8, large nuclei are observed on A2 and A6. Bar represents 10 µm. B. Table shows the percentage of 
multinuclear cells, and cells with large nuclei or micronuclei in HeLa cells or primary human fibroblasts, determined by cell 
counting under the microscope. n = 1740 for HeLa cells transfected with scrambled siRNA #1, n = 1380 for HeLa cells trans-
fected with nucleolin siRNA mix, n = 1560 for fibroblasts transfected with scrambled siRNA #1, n = 1220 for fibroblasts trans-
fected with nucleolin siRNA mix.
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Depletion of nucleolin induces hyper amplification of centrosome and multipolar mitotic spindle formation Figure 6
Depletion of nucleolin induces hyper amplification of centrosome and multipolar mitotic spindle formation. 
HeLa cells transfected for 4 days with control siRNA # 1 or with the nucleolin siRNA mix #2 and #4 were processed for 
immunofluorescence. Centromeres were stained with a CREST antiserum (CEN), microtubules with an α-tubulin antibody, 
centrosomal structures with a γ-tubulin antibody and DAPI was used to counterstained DNA. Views of 3D reconstructions are 
shown for each label and for merged labels as indicated.
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mid-late G1 [41]. Some B23 phosphorylated on Thr199
remained at the centrosome and seemed to be important
for the interaction of the ROCK II kinase that also regu-
lated centrosome duplication [59]. The regulated localiza-
tion of B23 at the centrosomes could represent one of the
licensing systems for centrosome duplication ensuring
only one duplication per cell cycle [40]. Although nucleo-
lin has been found associated with centrosomal structures
in the proteomic analysis of human centrosomes [44], we
have not been able to detect nucleolin in these structures
by immunofluorescence using different antibodies. How-
ever, localization of B23 protein at the centrosomes is not
easily detectable. Only a few B23 antibodies were able to
detect B23 protein at the centrosomal structure [60], while
conflicting data were obtained with GFP-B23 [42,60].
This may reflect an inaccessibility of the antibody to the
protein, post-translational modifications or an alteration
of the B23 structure when it was present at the centro-
somes. Interestingly, nucleolin interacts with B23 [43,61],
and several nucleolar proteins have been found associated
with centrosomal structures in the proteomic characteri-
zation of the human centrosome [44]. This could suggest
that a nucleolar protein complex could participate in the
regulation of centrosome duplication. Future experiments
should further explore this link between nucleolin and the
regulation of centrosome duplication.
Conclusion
In this report we uncovered a new role for nucleolin in cell
proliferation and cell division. Unexpectedly we found
that expression of nucleolin was required for a correct
mitosis and controlled centrosome duplication. We
expect that these findings will be useful to better under-
stand not only the complex function of nucleolin in the
cell but also the function of the nucleolar structure in
other processes that ribosome biogenesis.
Methods
Cell culture and transfection
HeLa cells plated in Dulbecco's modified Eagle's medium
(DMEM, Gibco BRL) supplemented with 10% (v/v) fetal
calf serum (FCS, Life Technologies, Inc.) and 1% penicil-
lin/streptomycin solution (Life Technologies, Inc.) were
maintained at 37°C in 5% CO2  incubator. Primary
human fibroblasts were grown in the same medium sup-
plemented with 15% (v/v) fetal calf serum. Mixtures of
functional siRNA specific for human nucleolin made by
SMART pool technology, a control RISC-free siRNA were
obtained from Dharmacon (Perbio Science France). Cells
were plated at 1 × 105 in 6 well dishes and transfected with
a final concentration of 100 nM siRNA by lipid transfec-
tion reagent DharmaFECT 1 from Dharmacon (Perbio
Science France) according to the manufacturer's instruc-
tions.
Cell proliferation and apoptosis assays
For FACS analysis, 1 × 106 cells of each sample were col-
lected by trypsinization, fixed in 70% ethanol, washed in
phosphate-buffered saline (PBS), resuspended in 1 ml of
PBS containing 1 mg/ml RNase and 50 µg/ml propidium
iodide, incubated in the dark for 30 min at room temper-
ature, and analyzed at ~200 cells/sec on a Becton-Dickin-
son (Lincoln, NJ) FACScan. The percentages of cells in
individual cell cycle phases were quantified with ModFit
LD software.
A TUNEL assay (Promega) was used to identify apoptotic
cells according to the supplier's recommendation. Briefly,
cells were trypsinized, washed twice with PBS, and placed
on glass slides using a Cytospin cytocentrifuge. Samples
were fixed in 4% paraformaldehyde in PBS for 25 min at
room temperature, and then permeabilized with 0.2% Tri-
ton X-100 (TX-100) in PBS for 10 min. After two washes
with PBS cells were incubated with equilibration buffer
for 10 min. Equilibration buffer was exchanged with TdT
incubation mixture containing fluorescein-12-dUTP in
the presence of terminal deoxynucleotidyl transferase
(TdT) to label 3'-OH ends of fragmented DNA. The slides
were incubated at 37°C for 60 min inside the humidified
chamber in the dark. The reaction was stopped by
immersing the slides in 2 × SSC for 15 min. After 3 washes
in PBS the slides were mounted in Fluoromount G con-
taining 400 ng/ml DAPI and analyzed with a fluorescence
microscope (Leica DM IRB) using a standard fluorescein
filter set. At least 400 cells were counted for each time
point in two different experiments.
Immunofluorescence and protein analysis
Cells were plated at 5 × 104 cells/well in 24 well dishes
onto glass coverslips. Samples were washed with PBS,
fixed in 4% paraformaldehyde in PBS for 5 min at room
temperature, incubated in ice cold methanol for 20 min
and then permeabilized with 0.1% Triton X-100 in PBS
for 2 × 5 min. After two washes with PBS, nonspecific
binding of antibodies was blocked by a 30 min incuba-
tion at room temperature with 10% fetal calf serum, 1%
BSA and 0.1% TX-100 in PBS. After three washes with PBS,
coverslips were incubated in primary antibodies at 37°C
for 30 min as indicated below. After two washes in PBS/
0.1% TX-100, coverslips were incubated with secondary
antibodies coupled to Alexa dyes (A488, A568 and A647).
After two more washes in PBS/0.1% TX-100, coverslips
were washed in PBS, rinsed in ddH2O and briefly dipped
in 100% EtOH. After a quick dry, coverslips were
mounted on a slide with Fluoromount G (EMS) contain-
ing 400 ng/ml DAPI.
For protein analysis, cells were lysed in a 50 mM Tris-HCl,
pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium
deoxycholate, 0.1% sodium dodecyl sulfate [SDS] buffer,BMC Molecular Biology 2007, 8:66 http://www.biomedcentral.com/1471-2199/8/66
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supplemented with complete protease cocktail inhibitor
(Roche). 5 × 104 or 2 × 105 cells per slot were loaded onto
a 10% SDS-polyacrylamide gel for electrophoresis and
then transferred to Protran membranes (Schleicher &
Schuell, Germany). Membranes were blocked in 5% milk,
washed with PBST (PBS with 0.1% Tween), and incubated
with the indicated primary antibodies. Following washing
and incubation with horseradish peroxidase-conjugated
anti-rabbit (Sigma) or anti-mouse (Sigma) antibody at
1:15000 and 1:5000 dilutions, respectively, in 5% milk,
membranes were washed and detected by ECL (Amer-
sham Biosciences) and exposed to x-ray film.
Antibodies for the detection of p53 (FL-393), cyclin A (H-
432), PH3-S28 and cyclin B1 (GNS1) (all diluted 1:250,
except 1:50 for PH3-S28) were obtained from Santa Cruz
Biotechnology, Santa Cruz, CA. Nucleolin was detected
with rabbit anti-nucleolin polyclonal antibody (A-
134)(1:1000), rabbit polyclonal anti-B23 antibody
(1:3000) was kindly gift from Dr M. Olson. A CREST
serum was used at 1/4000 to detect centromeres and
human auto-sera against fibrillarin and UBF were used at
1/100 (kind gifts from Dr. E. Tan, TSRI, La Jolla, USA).
PH3S10 was detected with a rabbit polyclonal serum
(kind gift from Dr. D. Allis, [48]) A directly coupled anti-
body against gamma-tubulin was used at 1/50 (Sigma).
Microscopic image acquisition and visualisation
Images of cells were obtained with a motorized Zeiss Axi-
oplan using a 63× objective lens (NA = 1.4), equipped
with a CoolSNAP HQ CCD camera driven by Metamorph
(Molecular Devices Corp., v. 6.3). Image stacks were col-
lected at intervals of 0.2 µm in the z axis for all cells and
processed using a 3D deconvolution procedure (Meta-
morph) using the measured PSF. Three to five sections
containing focused signals were chosen for projection
onto one plane for analysis (Figures 2B, C and 5A). Pro-
jections were further processed to generate digital masks
using the magic wand and stroke tools in Adobe ® Pho-
toshop to ease visualization of as many as four fluorescent
channels. Views of 3D reconstructions were generated
using Amira using the complete z-stacks (Figure 6).
Electron microscopy
Cells were fixed for 1 h at room temperature in a solution
composed of 1.6% glutaraldehyde in 0.1 M Sorensen's
buffer (pH 7.4). After three washes in the same buffer, the
samples were acetylated according to Thiry et al. [62]
before being embedded in Epon. Ultrathin sections
mounted on copper grids were stained with uranyl acetate
and lead citrate before examination with a Jeol CX 100
transmission electron microscope at 60 kV.
RNA extraction and Real Time-PCR
Total RNA was extracted with RNeasy kit (Qiagen, France)
and treated with DNase I (Promega). After extraction, the
integrity of total RNA was examined on a 1.2% agarose gel
containing 1 mg/ml ethidium bromide and quantified.
100 ng of total RNA were reverse-transcribed using ran-
dom primers and 1st Strand cDNA Synthesis Kit for RT-
PCR (Roche Molecular Biochemicals). Real-time PCRs
were performed with a Light Cycler 2.0 instrument (Roche
Molecular Diagnostics) in Light Cycler capillaries using a
commercially available master mix containing Taq DNA
polymerase and SYBR-Green I deoxyribonucleoside tri-
phosphates. Optimization reactions were first performed
until the best primers, probe concentrations, and cycling
conditions were established. After the addition of primers
(final concentration: 0.5 µM), MgCl2 (4 mM) and tem-
plate DNA to the master mix, 45 cycles of denaturation
(95°C for 1 s), annealing (58°C for 10 s) and extension
(72°C for 10 s) were performed. Cytoplasmic β-actin
and18S rRNA were analyzed in parallel to each PCR, and
the resulting actin and 18S rDNA measurements were
used as internal standards for quantification of the spe-
cific transcripts as indicated.
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